Arrivent Biopharma Inc (AVBP)

03:56 AM

How ArriVent BioPharma Inc. stock reacts to Fed rate cuts2025 Risk Factors & Weekly Watchlist for Consistent Profits - newser.com

03:56 AM

05:40 AM

Why ArriVent BioPharma Inc. stock is favored by pension fundsWeekly Trade Review & Fast Moving Stock Trade Plans - newser.com

05:40 AM

Oct 16, 2025

What’s the recovery path for long term holders of ArriVent BioPharma Inc.Trade Signal Summary & AI Forecasted Entry/Exit Points - newser.com

Oct 16, 2025

Oct 16, 2025

ArriVent BioPharma (NASDAQ:AVBP) Cut to Strong Sell at Zacks Research - Defense World

Oct 16, 2025

Oct 14, 2025

Total liabilities & shareholders' equities of ArriVent BioPharma, Inc. – BOATS:AVBP - TradingView

Oct 14, 2025

Oct 14, 2025

Analyzing ArriVent BioPharma Inc. with multi timeframe charts2025 Institutional Moves & Weekly Breakout Watchlists - newser.com

Oct 14, 2025

Oct 14, 2025

Is ArriVent BioPharma The Next Big Player In Targeted Cancer Therapies? - RTTNews

Oct 14, 2025

Oct 10, 2025

Is ArriVent BioPharma Inc. stock attractive after correctionWeekly Market Report & Low Volatility Stock Recommendations - newser.com

Oct 10, 2025

Oct 10, 2025

Should you hold or exit ArriVent BioPharma Inc. nowJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com

Oct 10, 2025

Oct 10, 2025

Can volume confirm reversal in ArriVent BioPharma Inc.July 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com

Oct 10, 2025

Oct 09, 2025

ArriVent BioPharma (NASDAQ:AVBP) Given Sell (D-) Rating at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

Will ArriVent BioPharma Inc. stock see PE expansion2025 Stock Rankings & AI Forecasted Stock Moves - newser.com

Oct 09, 2025

Oct 08, 2025

ArriVent BioPharma Secures Global Rights to MRG007 in Strategic Deal with Lepu Biopharma - MSN

Oct 08, 2025

Oct 06, 2025

Is it too late to sell ArriVent BioPharma Inc.2025 Momentum Check & Fast Moving Stock Trade Plans - newser.com

Oct 06, 2025

Oct 06, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Oct 06, 2025

Oct 05, 2025

Analyzing drawdowns of ArriVent BioPharma Inc. with statistical toolsWeekly Trend Recap & Smart Money Movement Tracker - newser.com

Oct 05, 2025

Oct 03, 2025

How moving averages guide ArriVent BioPharma Inc. tradingTrade Risk Assessment & Long-Term Safe Return Strategies - newser.com

Oct 03, 2025

Sep 30, 2025

Certain Options of ArriVent BioPharma, Inc. are subject to a Lock-Up Agreement Ending on 1-OCT-2025. - MarketScreener

Sep 30, 2025

Sep 30, 2025

Certain Common Stock of ArriVent BioPharma, Inc. are subject to a Lock-Up Agreement Ending on 1-OCT-2025. - MarketScreener

Sep 30, 2025

Sep 29, 2025

ArriVent BioPharma Taps Brent S. Rice as Chief Commercial Officer - MyChesCo

Sep 29, 2025

Sep 27, 2025

ArriVent BioPharma Reports Q1 2025 Financial Results and Highlights Key Achievements - MSN

Sep 27, 2025

Sep 26, 2025

ArriVent Reports Promising Results for Firmonertinib in Lung Cancer Patients With Rare EGFR Mutations - MSN

Sep 26, 2025

Sep 26, 2025

Can S.P.E.E.H. Hidroelectrica S.A. (E28) stock hold up in economic slowdownJuly 2025 Patterns & AI Powered Market Entry Strategies - newser.com

Sep 26, 2025

Sep 25, 2025

Is it time to cut losses on ArriVent BioPharma Inc.2025 Institutional Moves & Fast Moving Market Watchlists - newser.com

Sep 25, 2025

Sep 23, 2025

Custom watchlist performance reports with ArriVent BioPharma Inc. - newser.com

Sep 23, 2025

Sep 23, 2025

Goldman Sachs Group Inc. Reduces Holdings in ArriVent BioPharma, Inc. $AVBP - MarketBeat

Sep 23, 2025

Sep 22, 2025

ArriVent BioPharma appoints Brent Rice as chief commercial officer - Investing.com

Sep 22, 2025

Sep 22, 2025

ArriVent BioPharma appoints Brent Rice as chief commercial officer By Investing.com - Investing.com Nigeria

Sep 22, 2025

Sep 22, 2025

ArriVent Appoints Brent Rice as Chief Commercial Officer - citybiz

Sep 22, 2025